Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD38 | P28907 | 11/20 | 1.00 |
| ▸ | F2 | P00734 | 2/20 | 1.00 |
| ▸ | NR1H2 | P55055 | 1/20 | 1.00 |
| ▸ | NR1H3 | Q13133 | 1/20 | 1.00 |
| ▸ | GLO1 | Q04760 | 5/20 | 0.97 |
| ▸ | SNCA | P37840 | 3/20 | 0.97 |
| ▸ | DPP4 | P27487 | 3/20 | 0.97 |
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.76 |
| ▸ | EGFR | P00533 | 2/20 | 0.71 |
| ▸ | KDR | P35968 | 2/20 | 0.71 |
| ▸ | EP300 | Q09472 | 2/20 | 0.71 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.71 |
| ▸ | MAOA | P21397 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyanidin SCHEMBL20799 | 1.00 | CD38 (1.00) | CD38F2NR1H2NR1H3GLO1 | |
| Cyanidin SCHEMBL30423220 | 0.98 | CD38 (0.97) | CD38F2NR1H2NR1H3GLO1 | |
| Cyanidin SCHEMBL29742342 | 0.98 | CD38 (0.97) | CD38F2NR1H2NR1H3GLO1 | |
| Cyanidin SCHEMBL156277 | 0.98 | GLO1 (1.00) | CD38F2NR1H2NR1H3GLO1 | |
| Cyanidin SCHEMBL29547214 | 0.98 | GLO1 (1.00) | CD38F2NR1H2NR1H3GLO1 | |
| Cyanidin SCHEMBL608392 | 0.98 | CD38 (0.97) | CD38F2NR1H2NR1H3GLO1 | |
| Cyanidin SCHEMBL1644900 | 0.98 | CD38 (0.97) | CD38F2NR1H2NR1H3GLO1 | |
| Cyanidin SCHEMBL7931530 | 0.97 | GLO1 (0.97) | CD38F2NR1H2NR1H3GLO1 | |
| Cyanidin SCHEMBL1230940 | 0.97 | GLO1 (0.97) | CD38F2NR1H2NR1H3GLO1 | |
| Cyanidin SCHEMBL1945495 | 0.94 | CD38 (0.88) | CD38F2NR1H2NR1H3GLO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3346842-B1 | STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME | NOVONESIS PLANT BIOSOLUTIONS AS (DK) | 2026-03-25 | — | — | EP | claimed |
| EP-4698662-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2026-02-25 | — | — | EP | claimed |
| EP-4652232-A1 | NOVEL POROUS CARBONACEOUS MATERIAL, PROCESS FOR THE PREPARATION THEREOF, AND USES THEREOF | Centre National de la Recherche Scientifique (FR) | 2025-11-26 | — | — | EP | claimed |
| EP-3434256-B1 | TOPICAL HERBAL COMPOSITIONS | CHEMISCHES LABORATORIUM DR KURT RICHTER GMBH (DE) | 2025-11-12 | — | — | EP | claimed |
| EP-3699174-B1 | COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME | ILAB (KR) | 2025-11-12 | — | — | EP | claimed |
| EP-3363283-B1 | NOVEL MANDEVILLA PLANT AND METHOD FOR BREEDING SAME | SUNTORY FLOWERS LTD (JP) | 2025-05-21 | — | — | EP | claimed |
| EP-3397069-B1 | PET FOOD COMPOSITIONS | HILLS PET NUTRITION INC (US) | 2025-04-16 | — | — | EP | claimed |
| WO-2024220449-A9 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2025-04-03 | — | — | WO | claimed |
| WO-2024220449-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | ASKLEPIOS BIOPHARMACEUTICAL, INC. (US) | 2024-10-24 | — | — | WO | claimed |
| WO-2024153593-A1 | NOVEL POROUS CARBONACEOUS MATERIAL, PROCESS FOR THE PREPARATION THEREOF, AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-07-25 | — | — | WO | claimed |
| EP-3682831-B1 | CRYOGENIC APPLICATOR | DUTCH RENEWABLE ENERGY B V (NL) | 2024-05-08 | — | — | EP | claimed |
| EP-3823680-B1 | NITRIC OXIDE PRODUCING COLLAGEN/ORC DRESSING | SYSTAGENIX WOUND MAN LIMITED (GB) | 2024-03-06 | — | — | EP | claimed |
| EP-3035949-B1 | SUGAR CANE DERIVED EXTRACTS AND USES | Poly Gain Pte Ltd (SG) | 2023-10-04 | — | — | EP | claimed |
| EP-3538081-B1 | USE OF A SPERMIDINE COMPRISING EXTRACT FOR THE ENHANCEMENT OF MITOCHONDRIAL RESPIRATION | TLL THE LONGEVITY LABS GMBH (AT) | 2023-08-02 | — | — | EP | claimed |
| EP-3982924-B1 | PLANT EXTRACT MIXTURE FOR USE IN THE PREVENTION AND/OR TREATMENT OF CHRONIC INFLAMMATORY BOWEL DISEASES | VALBIOTIS (FR) | 2023-07-26 | — | — | EP | claimed |
| EP-3573748-B1 | COLOURED ORGANIC/INORGANIC HYBRID MATERIALS AND METHOD FOR PREPARING SAME | CENTRE NAT RECH SCIENT (FR) | 2023-04-19 | — | — | EP | claimed |
| EP-3397068-B1 | PET FOOD COMPOSITIONS | HILLS PET NUTRITION INC (US) | 2022-09-14 | — | — | EP | claimed |
| WO-2022180651-A1 | COMPOSITION FOR PREVENTING AND OR TREATING SKIN AND HAIR DISORDERS | ANTONUCCI TAROLLA NICOLA TITO PIERLUCA (IT) | 2022-09-01 | — | — | WO | claimed |
| EP-3533454-B1 | COMPOSITION COMPRISING A MIXTURE OF PLANT EXTRACTS OR A MIXTURE OF MOLECULES CONTAINED IN SAID PLANTS AND USE TO ACT ON THE CARBOHYDRATE AND/OR LIPID METABOLISM | VALBIOTIS (FR) | 2022-04-20 | — | — | EP | claimed |
| EP-4082552-B1 | LIQUIDS RICH IN NOBLE GAS AND METHODS OF THEIR PREPARATION AND USE | UNIV TEXAS (US) | 2026-05-06 | — | — | EP | disclosed |
| WO-2026060768-A1 | METHOD FOR CONSTRUCTING CHASSIS CELL LINE USED FOR DIRECTED SYNTHESIS OF ANTHOCYANIN AND USE THEREOF | 成都新朝阳作物科学股份有限公司 | 2026-03-26 | — | — | WO | disclosed |
| EP-4698662-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2026-02-25 | — | — | EP | disclosed |
| US-20260048066-A1 | TREATMENT OF NEURODEGENERATIVE DISORDERS UTILISING METHYLTHIONINIUM (MT)-CONTAINING COMPOUNDS | WISTA LABORATORIES LTD (SG) | 2026-02-19 | — | — | US | disclosed |
| WO-2026033022-A1 | GENES, PROTEINS, AND PROCESSES FOR THE SYNTHESIS OF BLUE AND RED ANTHOCYANINS | Leibniz-Institut für Pflanzenbiochemie (IPB) Stiftung des öffentlichen Rechts (DE) | 2026-02-12 | — | — | WO | disclosed |
| EP-3740187-B1 | INSTANTANEOUS NATURAL COLORANTS AND PROCESSES OF MAKING THE SAME | MENESES DA SILVA EDNA (FR) | 2025-12-10 | — | — | EP | disclosed |
| EP-4385512-B1 | OPTIMISED DOSAGE OF DIAMINOPHENOTHIAZINES IN POPULATIONS | TAURX THERAPEUTICS MAN LTD (GB) | 2025-12-03 | — | — | EP | disclosed |
| EP-4652232-A1 | NOVEL POROUS CARBONACEOUS MATERIAL, PROCESS FOR THE PREPARATION THEREOF, AND USES THEREOF | Centre National de la Recherche Scientifique (FR) | 2025-11-26 | — | — | EP | disclosed |
| US-12465627-B2 | Immunity-boosting agent, immuno-therapeutic anti-cancer agent, and anti-cancer therapy adverse effect mitigating agent containing anthocyanin-fucoidan complex as active ingredient | JBKLAB CO., LTD. (KR) | 2025-11-11 | — | — | US | disclosed |
| US-12458618-B2 | Compounds and methods for the detection of TRPV-6 cancers and drug delivery | SORICIMED BIOPHARMA INC. (CA) | 2025-11-04 | — | — | US | disclosed |
| US-20250302843-A1 | OPTIMISED DOSAGE OF DIAMINOPHENOTHIAZINES IN POPULATIONS | WISTA LABORATORIES LTD. (SG) | 2025-10-02 | — | — | US | disclosed |
| US-12409109-B2 | Dry mixture and personal care composition as well as methods for their production | WEIDMANN HOLDING AG (CH) | 2025-09-09 | — | — | US | disclosed |
| US-20250268801-A1 | DRY CREAMS AND TOPICAL DELIVERY SYSTEMS | UEA ENTERPRISES LIMITED (GB) | 2025-08-28 | — | — | US | disclosed |
| EP-4335517-B1 | ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES | WISTA LAB LTD (SG) | 2025-08-27 | — | — | EP | disclosed |
| US-20250262219-A1 | ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES | WISTA LABORATORIES LTD. (SG) | 2025-08-21 | — | — | US | disclosed |
| WO-2025158468-A1 | CYANIDIN-3-GLUCOSIDE (C3G) FORMULATIONS AND A METHOD OF EXTRACTING C3G FROM PURPLE CORN WHOLE COB | PURPLE LIFE SCIENCES PRIVATE LIMITED (IN) | 2025-07-31 | — | — | WO | disclosed |
| WO-2025132033-A1 | COLOURED POWDERS OF NATURAL ORIGIN AND USES | L V M H RECHERCHE (FR) | 2025-06-26 | — | — | WO | disclosed |
| EP-4561368-A1 | STEVIOL GLYCOSIDE COMPOSITIONS WITH IMPROVED PROPERTIES | Purecircle SDN BHD (MY) | 2025-06-04 | — | — | EP | disclosed |
| US-12310973-B2 | Administration and dosage of diaminophenothiazines | WISTA LABORATORIES LTD. (SG) | 2025-05-27 | — | — | US | disclosed |
| WO-2025089084-A1 | INKJET INK AND INK SET | DIC株式会社 | 2025-05-01 | — | — | WO | disclosed |
| US-12280061-B2 | Optimised dosage of diaminophenothiazines in populations | WISTA LABORATORIES LTD. (SG) | 2025-04-22 | — | — | US | disclosed |
| US-20250114419-A1 | INTESTINAL HEALTH PROMOTING COMPOSITIONS | NSE PRODUCTS, INC. | 2025-04-10 | — | — | US | disclosed |
| WO-2024220449-A9 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2025-04-03 | — | — | WO | disclosed |
| US-12263175-B2 | Optimised dosage of diaminophenothiazines in populations | WISTA LABORATORIES LTD. (SG) | 2025-04-01 | — | — | US | disclosed |
| WO-2025051825-A1 | COMPOSITION BASED ON POMEGRANATE EXTRACT ASSOCIATED WITH PROBIOTICS, INTENDED TO CORRECT SKIN DISORDERS CAUSED BY POLLUTION AND/OR UV RADIATION | TeloSmetic (FR) | 2025-03-13 | — | — | WO | disclosed |
| US-20240382389-A1 | DRY MIXTURE AND PERSONAL CARE COMPOSITION AS WELL AS METHODS FOR THEIR PRODUCTION | WEIDMANN HOLDING AG (CH) | 2024-11-21 | — | — | US | disclosed |
| US-12128051-B2 | Administration and dosage of diaminophenothiazines | WISTA LABORATORIES LTD. (SG) | 2024-10-29 | — | — | US | disclosed |
| WO-2024220449-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | ASKLEPIOS BIOPHARMACEUTICAL, INC. (US) | 2024-10-24 | — | — | WO | disclosed |
| US-20240317699-A1 | A PROCESS FOR THE PURIFICATION OF ANTHOCYANINS AND ANTHOCYANIDINS FROM NATURAL EXTRACTS USING ADSORPTION RESINS AND ACIDIFIED WATER AS DESORBENT | AMERICAN BIOPROCESS SpA (CL) | 2024-09-26 | — | — | US | disclosed |
| EP-3826639-B1 | OPTIMISED DOSAGE OF DIAMINOPHENOTHIAZINES IN POPULATIONS | WISTA LAB LTD (SG) | 2024-08-21 | — | — | EP | disclosed |
| WO-2024153593-A1 | NOVEL POROUS CARBONACEOUS MATERIAL, PROCESS FOR THE PREPARATION THEREOF, AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-07-25 | — | — | WO | disclosed |
| EP-3643775-B1 | BACILLUS AMYLOLIQUEFACIENS QV15 STIMULANT FOR THE SECONDARY METABOLISM OF PHENOLIC COMPOUNDS AND THE INHIBITORY CAPACITY OF RASPBERRY AND STRAWBERRY EXTRACTS FOR ENZYMES RELATED TO METABOLIC SYNDROME | FUNDACION UNIV SAN PABLO (ES) | 2024-07-03 | — | — | EP | disclosed |
| EP-4385512-A1 | OPTIMISED DOSAGE OF DIAMINOPHENOTHIAZINES IN POPULATIONS | WisTa Laboratories Ltd. (SG) | 2024-06-19 | — | — | EP | disclosed |
| EP-4364801-A2 | OPTIMISED DOSAGE OF DIAMINOPHENOTHIAZINES IN POPULATIONS | WisTa Laboratories Ltd. (SG) | 2024-05-08 | — | — | EP | disclosed |
| US-20240114931-A1 | BEVERAGES INCLUDING STEVIOL GLYCOSIDES AND A FOAM SUPPRESSING AGENT | CORN PRODUCTS DEVELOPMENT, INC. | 2024-04-11 | — | — | US | disclosed |
| EP-4335517-A2 | ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES | WisTa Laboratories Ltd. (SG) | 2024-03-13 | — | — | EP | disclosed |
| US-20240057642-A1 | BEVERAGES COMPRISING REB A AND STEVIOL GLYCOSIDES | CORN PRODUCTS DEVELOPMENT, INC. | 2024-02-22 | — | — | US | disclosed |
| US-11890590-B2 | Colored organic/inorganic hybrid materials and method for preparing same | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-02-06 | — | — | US | disclosed |
| WO-2024025408-A1 | STEVIOL GLYCOSIDE COMPOSITIONS WITH IMPROVED PROPERTIES | PURECIRCLE SDN BHD (MY) | 2024-02-01 | — | — | WO | disclosed |
| EP-4271204-A1 | BEVERAGES INCLUDING STEVIOL GLYCOSIDES AND A FOAM SUPPRESSING AGENT | CORN Products Development Inc. (US) | 2023-11-08 | — | — | EP | disclosed |
| EP-4271205-A1 | BEVERAGES COMPRISING REB A AND STEVIOL GLYCOSIDES | CORN Products Development Inc. (US) | 2023-11-08 | — | — | EP | disclosed |
| US-20230346794-A1 | ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES | WISTA LABORATORIES LTD. (SG) | 2023-11-02 | — | — | US | disclosed |
| EP-4265237-A1 | HAIR CARE OR HAIR CLEANSING OR SKIN CARE OR SKIN CLEANSING COMPOSITION | Weidmann Holding AG (CH) | 2023-10-25 | — | — | EP | disclosed |
| EP-3606500-B1 | PERSONAL CARE COMPOSITION | WEIDMANN HOLDING AG (CH) | 2023-10-04 | — | — | EP | disclosed |
| US-20230293613-A1 | METHODS AND RELATED COMPOSITIONS FOR REDUCING OXIDATIVE STRESS | OBEN JULIUS (CM) | 2023-09-21 | — | — | US | disclosed |
| US-11759469-B2 | Administration and dosage of diaminophenothiazines | WISTA LABORATORIES LTD. (SG) | 2023-09-19 | — | — | US | disclosed |
| EP-4239124-A2 | DRY MIXTURE | Weidmann Holding AG (CH) | 2023-09-06 | — | — | EP | disclosed |
| EP-4223297-A2 | ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES | WisTa Laboratories Ltd. (SG) | 2023-08-09 | — | — | EP | disclosed |
| EP-3982924-B1 | PLANT EXTRACT MIXTURE FOR USE IN THE PREVENTION AND/OR TREATMENT OF CHRONIC INFLAMMATORY BOWEL DISEASES | VALBIOTIS (FR) | 2023-07-26 | — | — | EP | disclosed |
| US-11696876-B2 | Hair care or hair cleansing composition or skin care or skin cleansing composition | Weidmann Holdino AG (CH) | 2023-07-11 | — | — | US | disclosed |
| US-11684646-B2 | Methods and related compositions for reducing oxidative stress | GATEWAY HEALTH ALLIANCES, INC. (US) | 2023-06-27 | — | — | US | disclosed |
| WO-2023108790-A1 | PROCESS FOR EXTRACTING ANTHOCYANIN FROM BLACK CORN | 海南拉风农业科技有限公司 | 2023-06-22 | — | — | WO | disclosed |
| US-20230165877-A1 | ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES | WISTA LABORATORIES LTD. (SG) | 2023-06-01 | — | — | US | disclosed |
| EP-3487505-B1 | ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES | WISTA LAB LTD (SG) | 2023-05-03 | — | — | EP | disclosed |
| US-20230132001-A1 | IMMUNITY-BOOSTING AGENT, IMMUNO-THERAPEUTIC ANTI-CANCER AGENT, AND ANTI-CANCER THERAPY ADVERSE EFFECT MITIGATING AGENT CONTAINING ANTHOCYANIN-FUCOIDAN COMPLEX AS ACTIVE INGREDIENT | JBKLAB CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| EP-3573748-B1 | COLOURED ORGANIC/INORGANIC HYBRID MATERIALS AND METHOD FOR PREPARING SAME | CENTRE NAT RECH SCIENT (FR) | 2023-04-19 | — | — | EP | disclosed |
| US-20230115931-A1 | OPTIMISED DOSAGE OF DIAMINOPHENOTHIAZINES IN POPULATIONS | WISTA LABORATORIES LTD. (SG) | 2023-04-13 | — | — | US | disclosed |
| EP-3573749-B1 | PHOTOLUMINESCENT HYBRID ORGANIC/INORGANIC MATERIALS AND METHOD FOR PREPARING SAME | CENTRE NAT RECH SCIENT (FR) | 2023-04-12 | — | — | EP | disclosed |
| US-11590475-B2 | Photoluminescent hybrid organic/inorganic materials and method for preparing same | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2023-02-28 | — | — | US | disclosed |
| US-20230026978-A1 | PHOTOISOMERIZED COMPOSITIONS OF ANTHOCYANINS AND METHODS OF MAKING AND USE THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2023-01-26 | — | — | US | disclosed |
| WO-2023284777-A1 | COPOLYMER FILM, ENZYME CATALYSIS SELF-ASSEMBLY SYNTHESIS METHOD THEREFOR, AND APPLICATION THEREOF | 中国科学院天津工业生物技术研究所 | 2023-01-19 | — | — | WO | disclosed |
| WO-2022269211-A1 | HEAT-RESISTANT DYE BASED ON PIGMENTS OF NATURAL ORIGIN, USE THEREOF AND OBJECTS CONTAINING SAME | LUMA/ARLES (FR) | 2022-12-29 | — | — | WO | disclosed |
| US-20220381779-A1 | METHODS FOR THE DIAGNOSIS OF BURULI ULCER | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2022-12-01 | — | — | US | disclosed |
| US-11491184-B2 | Liquids rich in noble gas and methods of their preparation and use | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-11-08 | — | — | US | disclosed |
| EP-4082552-A1 | LIQUIDS RICH IN NOBLE GAS AND METHODS OF THEIR PREPARATION AND USE | The Board of Regents of the University of Texas System (US) | 2022-11-02 | — | — | EP | disclosed |
| US-20220322719-A1 | INTESTINAL HEALTH PROMOTING COMPOSITIONS | NSE PRODUCTS, INC. (US) | 2022-10-13 | — | — | US | disclosed |
| WO-2022188841-A1 | HISTONE DEACETYLASE INHIBITOR AND APPLICATION THEREOF | 微境生物医药科技(上海)有限公司 | 2022-09-15 | — | — | WO | disclosed |
| EP-4055385-A1 | METHODS FOR THE DIAGNOSIS OF BURULI ULCER | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2022-09-14 | — | — | EP | disclosed |
| WO-2022180651-A1 | COMPOSITION FOR PREVENTING AND OR TREATING SKIN AND HAIR DISORDERS | ANTONUCCI TAROLLA NICOLA TITO PIERLUCA (IT) | 2022-09-01 | — | — | WO | disclosed |
| US-11426421-B2 | Composition for preventing or improving inflammation including extract of seed of new soybean cultivar SCEL-1 | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2022-08-30 | — | — | US | disclosed |
| WO-2022147279-A1 | BEVERAGES COMPRISING REB A AND STEVIOL GLYCOSIDES | CORN PRODUCTS DEVELOPMENT, INC. (US) | 2022-07-07 | — | — | WO | disclosed |
| WO-2022147254-A1 | BEVERAGES INCLUDING STEVIOL GLYCOSIDES AND A FOAM SUPPRESSING AGENT | CORN PRODUCTS DEVELOPMENT, INC. (US) | 2022-07-07 | — | — | WO | disclosed |
| WO-2022139544-A1 | COMPOSITION FOR PREVENTING OR TREATING MUSCLE DISEASES CONTAINING ARONIA OR HOUTTUYNIA CORDATA EXTRACT AS ACTIVE INGREDIENT | 고려대학교 산학협력단 | 2022-06-30 | — | — | WO | disclosed |
| US-20220175977-A1 | COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY | SORICIMED BIOPHARMA INC. (CA) | 2022-06-09 | — | — | US | disclosed |
| US-20220160591-A1 | HAIR CARE OR HAIR CLEANSING COMPOSITION OR SKIN CARE OR SKIN CLEANSING COMPOSITION | WEIDMANN HOLDING AG (CH) | 2022-05-26 | — | — | US | disclosed |
| EP-3533454-B1 | COMPOSITION COMPRISING A MIXTURE OF PLANT EXTRACTS OR A MIXTURE OF MOLECULES CONTAINED IN SAID PLANTS AND USE TO ACT ON THE CARBOHYDRATE AND/OR LIPID METABOLISM | VALBIOTIS (FR) | 2022-04-20 | — | — | EP | disclosed |
| CN-114369079-A | Extraction process of black corn anthocyanin | 海南拉风农业科技有限公司 | 2022-04-19 | — | — | CN | disclosed |
| US-20220105017-A1 | TOPICAL MACQUI BERRY FORMULATION | TRACIE MARTYN INT INC (US) | 2022-04-07 | — | — | US | disclosed |
| EP-2968126-B1 | LIQUIDS RICH IN NOBLE GAS AND METHODS OF THEIR PREPARATION AND USE | UNIV TEXAS (US) | 2022-04-06 | — | — | EP | disclosed |
| US-11278475-B2 | Personal care composition | WEIDMANN HOLDING AG (CH) | 2022-03-22 | — | — | US | disclosed |
| EP-3966127-A1 | CAPSULE CONTAINING MATERIAL SUCH AS BEVERAGE POWDER, IN PARTICULAR FOR PREPARING BREWED COFFEE | Swiss Coffee Innovation AG (CH) | 2022-03-16 | — | — | EP | disclosed |
| EP-3966127-A1 | CAPSULE CONTAINING MATERIAL SUCH AS BEVERAGE POWDER, IN PARTICULAR FOR PREPARING BREWED COFFEE | Swiss Coffee Innovation AG (CH) | 2022-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (14 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260048066-A1 | TREATMENT OF NEURODEGENERATIVE DISORDERS UTILISING METHYLTHIONINIUM (MT)-CONTAINING COMPOUNDS | MAPT, PARK7, TARDBP | CD38 4603/4885F2 3450/4885NR1H2 4437/4885 |
| US-12280061-B2 | Optimised dosage of diaminophenothiazines in populations | MAPT, TPMT, LMTK2 | CD38 2609/4885F2 3962/4885NR1H2 2270/4885 |
| US-20230115931-A1 | OPTIMISED DOSAGE OF DIAMINOPHENOTHIAZINES IN POPULATIONS | MAPT, TPMT, LMTK2 | CD38 2609/4885F2 3962/4885NR1H2 2270/4885 |
| US-20230293613-A1 | METHODS AND RELATED COMPOSITIONS FOR REDUCING OXIDATIVE STRESS | CAT, PRDX3, PRDX6 | CD38 2586/4885F2 1761/4885NR1H2 988/4885 |
| US-11759469-B2 | Administration and dosage of diaminophenothiazines | ACHE, BCHE, PNMT | CD38 3758/4885F2 4583/4885NR1H2 2105/4885 |
| US-20250302843-A1 | OPTIMISED DOSAGE OF DIAMINOPHENOTHIAZINES IN POPULATIONS | MAPT, TPMT, LMTK2 | CD38 2609/4885F2 3962/4885NR1H2 2270/4885 |
| US-11890590-B2 | Colored organic/inorganic hybrid materials and method for preparing same | IK, VCL, VIM | CD38 3653/4885F2 654/4885NR1H2 4142/4885 |
| US-20230165877-A1 | ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES | ACHE, BCHE, PNMT | CD38 3758/4885F2 4583/4885NR1H2 2105/4885 |
| US-12263175-B2 | Optimised dosage of diaminophenothiazines in populations | MAPT, TPMT, LMTK2 | CD38 2609/4885F2 3962/4885NR1H2 2270/4885 |
| US-12128051-B2 | Administration and dosage of diaminophenothiazines | ACHE, BCHE, PNMT | CD38 3758/4885F2 4583/4885NR1H2 2105/4885 |
| US-11684646-B2 | Methods and related compositions for reducing oxidative stress | CAT, PRDX3, PRDX6 | CD38 2586/4885F2 1761/4885NR1H2 988/4885 |
| US-20250262219-A1 | ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES | ACHE, BCHE, PNMT | CD38 3758/4885F2 4583/4885NR1H2 2105/4885 |
| US-20230346794-A1 | ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES | ACHE, BCHE, PNMT | CD38 3794/4885F2 4549/4885NR1H2 2274/4885 |
| US-12310973-B2 | Administration and dosage of diaminophenothiazines | ACHE, BCHE, PNMT | CD38 3794/4885F2 4549/4885NR1H2 2274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.